If you experience worsening neurological symptoms such as increasing weakness, loss of balance, or new symptoms, this requires prompt medical assessment rather than being considered part of normal adjustment
The injection site may be slightly sore or bruised for a short time
Safety across the full program was consistently favorable: adverse events, primarily mild headache and gastrointestinal symptoms, occurred at rates comparable to placebo, with no treatment-related discontinuations, no IGF-1 elevation, and no impact on glucose metabolism
Below, you will find a plain-English breakdown of what Cerebrolysin is, how it works, what the research suggests, how it compares to other neuropeptides, and how Robertson Wellness and Aesthetics in Beverly Hills approaches Cerebrolysin peptide therapy
Retatrutide is administered as a once-weekly subcutaneous injection of up to 12 mg
We believe the quartile-based approach in conjunction with the requirement of at least three Safety of Care measures provides a suitable balance between emphasizing Safety of Care broadly across all hospitals (not just at a few extremely low performers) while also ensuring that only hospitals with demonstrably below-average performance would be subject to Overall Hospital Quality Star Rating reduction
